Lawrence Jengar
Sep 23, 2026 11:44
NVDA sits at $229.55 with every moving average below it and 58 out of 59 Wall Street analysts rating it a buy — but a dead-flat MACD and an overbought Stochastic are flashing a short-term warning. …
A $5-Trillion Machine That’s Still Undervalued — And the Market Is Finally Waking Up
NVIDIA doesn’t trade like a semiconductor company anymore. It trades like a toll road on the entire global AI economy. Q2 FY2027 results, reported August 26, made that case louder than any analyst pitch deck: revenue hit $96.2 billion, up 106% year-over-year, with data center revenue alone surging 117% to $89 billion. Gross margins held at 75%. EPS of $2.22 beat consensus by $0.13 — the fifth consecutive beat. Jensen Huang wasn’t understating it when he said “compute is revenue.” That’s not CEO theater; it’s a description of a structural shift that is still in its early innings.
What makes the current price entry interesting is the valuation reset that has quietly happened. The trailing P/E has compressed from 57x a year ago to roughly 27x today. The forward P/E sits at 23.6x — historically cheap for a company projecting 93.9% earnings growth in FY2027 and 65.8% in FY2028. The PEG ratio has collapsed to 0.45, which means you are paying less than half a turn of growth for each unit of earnings expansion. For a company with a $5.17 trillion market cap and a $303 billion trailing revenue base, that compression story is what keeps institutional investors reaching for more at every pullback. Readers tracking AI infrastructure stories on Blockchain.news will recognize the hyperscaler capex narrative driving this: top-five cloud providers are collectively tracking toward nearly $800 billion in capex in 2026, rising to an estimated $1.3 trillion in 2027. NVIDIA owns the picks-and-shovels position in that buildout, and the guidance for Q3 FY2027 at $108 billion confirms the trajectory isn’t slowing.
The Technical Structure Says: Buy the Dip, Don’t Chase the Print
At $229.55, NVDA is trading cleanly above every meaningful moving average — the 7-day SMA at $224.66, the 20-day at $222.84, the 50-day at $221.60. That stacking alignment is unambiguously bullish from a trend structure standpoint. The price is also sitting in the upper portion of its Bollinger Band envelope, with the %B reading of 0.77 telling you the stock is elevated relative to its recent range, but not yet at the band extreme. The upper band caps at $235.34, meaning there’s roughly $5.79 of headroom before the stock starts running hot.
Where this gets nuanced is the momentum picture. The MACD histogram has flat-lined at zero — the signal and MACD lines are essentially on top of each other. That doesn’t mean reversal; it means the impulse from the last leg higher has been absorbed and buyers need to show up again to extend the move. More pressing is the Stochastic: the %K at 97.22 is deep in overbought territory. In a trending market that kind of reading can persist, but when the MACD is simultaneously stalling, it signals that short-term traders are running out of easy fuel.
Immediate resistance sits at $231.19, with stronger resistance at $232.82. A clean break above $232.82 on volume would be the green light to extend toward the Bollinger upper band at $235 and then the 52-week high of $236.54. On the downside, immediate support is at $226.86, and the real line in the sand is the $224.16 strong support level — which also nearly coincides with the 7-day SMA. A close below $224 would signal that the short-term structure has broken and a re-test of the $221-$222 zone, near the 20-day and 50-day MAs, becomes the base case. With a daily ATR of $4.01, any of these moves are entirely achievable within a single session, so position sizing discipline is non-negotiable here.
The derivatives positioning backs the bullish lean: smart money long/short ratios sit at 1.62, with 61.8% of top-trader accounts positioned long. Open interest has grown 1.98% in 24 hours to over $156 million in notional value, suggesting fresh money entering rather than short covering. The funding rate at 0.0057% is essentially neutral — no sign of an overleveraged long side that could trigger a cascade. Taker flow is the one cautionary note, with sell volume slightly edging buy volume at a 0.905 ratio. That’s the market telling you it is absorbing supply rather than aggressively demanding stock. Not a sell signal — more a “show me” signal. You can track how this setup evolves alongside broader digital asset and equity tokenization developments at Blockchain.news.
Wall Street Has Made Its Call — And the Numbers Are Unambiguous
Fifty-nine analysts cover NVDA. Fifty-eight say buy. One says sell. Two say hold. The mean 12-month price target is $327.70. The high target is $515. The low target is $180. At the current price of $229.55, the consensus mean represents roughly 43% upside over the next 12 months. Goldman Sachs has a $300 target with a buy. BMO Capital is at $340. Cantor Fitzgerald is at $350. TD Cowen sits at $340. Even after five straight earnings beats and a stock already up 20% year-to-date, the sell-side hasn’t blinked.
The FY2027 EPS consensus has just been revised upward from $8.91 to $9.25 following the August earnings beat, with 13 upward estimate revisions in the past 30 days and zero downward. FY2028 consensus is at $15.33. Put a conservative 22x multiple on the FY2028 number and you’re already at $337 — above the current Street mean target. That’s the fundamental gravity pulling this stock higher. The company also has $99 billion remaining in its share repurchase authorization and now pays an annual dividend of $1.00, yielding 0.47%. For a name this size to be conducting aggressive buybacks while growing revenue at triple digits is almost absurd from a capital allocation standpoint, and it explains why the institutional ownership base of 71.4% shows no sign of distribution.
Revenue is guided to accelerate further: sales are projected to rise 88% in FY2027 and another 65.5% in FY2028. At a trailing revenue run rate of $303 billion, this is no longer a small-cap growth story where you close your eyes and pray. This is a company printing cash at a scale that makes the P/E compression argument almost irresistible to anyone running a 12-18 month book.
The 7-to-30-Day Trade: Two Paths, One High-Conviction Setup
Bull case (65% probability): NVDA consolidates in the $226-$231 range over the next 3-5 sessions, allowing the Stochastic to work off its overbought condition while the MACD begins to recurl upward. A reclaim of $231.19 with volume confirmation — call it a close above $232 — opens the door to $235-$236.54 in the near term. Carry that momentum through October and the $241-$245 range becomes the realistic 30-day target as the market begins pricing in Q3 FY2027 numbers (guided at $108 billion). Entry zone: $226-$228 on any intraday dip. Stop: Hard close below $221.50. Target: $238-$245.
Bear case (35% probability): The flat MACD and overbought Stochastic trigger a more meaningful pullback. Sellers lean on the $231-$232 resistance and push price back through the pivot at $228.49. If $226.86 immediate support cracks on a volume spike, the retracement extends to the $221-$222 zone where the 20-day and 50-day SMAs converge. That level would represent a flush of roughly 3.5% from current levels — healthy, not catastrophic — and would actually set up an even cleaner re-entry with better risk/reward ahead of Q3 earnings. Stop for swing long: $220.99. Do not add below $220 without a confirmed reversal candle.
The medium-term picture — 60 to 90 days — is harder to fade. With hyperscaler capex commitments locked in, a $108 billion Q3 guidance print, and 58 of 59 analysts holding a buy rating with an average 12-month target 43% above the current price, this stock wants to go higher. The structural AI demand cycle NVIDIA is monetizing isn’t a quarterly narrative; it’s a multi-year infrastructure buildout, and Blockchain.news has been tracking the intersection of AI compute and digital infrastructure through each phase of this cycle. Traders who get shaken out at $221 on a technical flush while the fundamentals scream otherwise tend to be the same ones chasing at $280.
The near-term risk is a technical pause. The medium-term risk is macro — Fed policy, a risk-off rotation, or any signal that hyperscaler capex commitments are being delayed. Neither of those looks likely in the immediate window. The dominant path is higher.
Fundamental data, analyst ratings and price targets are sourced from Yahoo Finance as of September 23, 2026 and reflect consensus estimates, not investment advice.
Image source: Shutterstock
Be the first to comment